| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/02/2005 | EP1509209A1 Compositions and method for transmucosal drug delivery and cryoprotection |
| 03/02/2005 | EP1509207A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 03/02/2005 | EP1509205A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 03/02/2005 | EP1509203A2 Delivery of nucleic acid-like compounds |
| 03/02/2005 | EP1509202A1 Novel high viscosity embolizing compositions comprising prepolymers |
| 03/02/2005 | EP1509201A1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 03/02/2005 | EP1509200A1 Film-shaped, dissolvable preparations for active substance release and method for the production thereof |
| 03/02/2005 | EP1509199A1 Dry powder inhalant composition |
| 03/02/2005 | EP1509182A1 Implantable polymeric device for sustained release of buprenorphine |
| 03/02/2005 | EP1421115B1 Soluble t cell receptor |
| 03/02/2005 | EP1345591B1 Pharmaceutical aerosol formulation |
| 03/02/2005 | EP1296650B1 Methods and compositions for treating pain of the mucous membrane |
| 03/02/2005 | EP1257695A4 Biomolecules having multiple attachment moieties for binding to a substrate surface |
| 03/02/2005 | EP1241943B1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 03/02/2005 | EP1201762B1 Process for producing lycopen |
| 03/02/2005 | EP1180102B9 Mutual prodrugs of amlodipine and atorvastatin |
| 03/02/2005 | EP1140240B1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 03/02/2005 | EP1140017B1 Water-insoluble drug delivery system |
| 03/02/2005 | EP1135105B1 Use of a neurologic agent for the manufacture of a medicament for the treatment of a central nervous system disorder |
| 03/02/2005 | EP1119347B1 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
| 03/02/2005 | EP1109532B1 Oral micro-emulsion composition of silybin |
| 03/02/2005 | EP1034207B1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 03/02/2005 | CN1589166A Stent coated with a sustained-release drug delivery system and method for use thereof |
| 03/02/2005 | CN1589157A Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin |
| 03/02/2005 | CN1589156A Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589149A Reduced toxicity cisplatin formulations and methods for using the same |
| 03/02/2005 | CN1589144A Use of an ascomycin for the treatment of blepharitis |
| 03/02/2005 | CN1589142A Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 03/02/2005 | CN1589141A Medicament for the treatment of viral skin and tumour diseases |
| 03/02/2005 | CN1589139A Modified release tamsulosin tablets |
| 03/02/2005 | CN1586624A Water soluble chitose intervention embolism chemical therapeutic medicine slow release gel microball |
| 03/02/2005 | CN1586623A Hollow fiber medicine carrier and its preparing method and use |
| 03/02/2005 | CN1586604A Zedoary injection preparation and its preparing method |
| 03/02/2005 | CN1586508A Method for preparing chuanxiong rhizome volatile beta-cyclic dextrin clathrate compound by colloid mill |
| 03/02/2005 | CN1586488A Chitosan glycyrrhizic acid nano particle and its preparing method |
| 03/02/2005 | CN1191272C Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 03/02/2005 | CN1191270C Cellulose binding domain |
| 03/02/2005 | CN1191093C DOS compounds an method for assaying the same |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/02/2005 | CN1191067C Lipid composition of high non-soluble platinum matches and lipid body |
| 03/02/2005 | CN1191062C Medicinal compositions |
| 03/02/2005 | CN1191061C Medical compositions |
| 03/02/2005 | CN1191060C Topical compositions for prostaglandin El delivery |
| 03/02/2005 | CN1191018C Chewing gum component for eliminating nicotine |
| 03/01/2005 | US6861519 Soluble highly branched glucose polymers and their method of production |
| 03/01/2005 | US6861447 Method for producing a coenzyme Q10/γ-cyclodextrin complex |
| 03/01/2005 | US6861410 Immunological adjuvant compositions |
| 03/01/2005 | US6861407 Methods of therapy with thrombin derived peptides |
| 03/01/2005 | US6861072 Pharmaceutical composition with gastric residence and controlled release |
| 03/01/2005 | US6861071 Highly absorptive solid preparation |
| 03/01/2005 | US6861069 Compression; concurrent spray drying, granulation |
| 03/01/2005 | US6861068 A polyorthoester and an excipient carrying antiemetic agents and anesthetics; topical or injectable forms; post operative or chemotherapy-induced emesis |
| 03/01/2005 | US6861067 Hydrogel wound dressing and the method of making and using the same |
| 03/01/2005 | US6861064 Encapsulation method |
| 03/01/2005 | US6861044 Radioiodinated sulfonated phenols and process therefore |
| 03/01/2005 | US6861016 Apparatus and method for preparing microparticles |
| 03/01/2005 | US6860907 Method of particle formation |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 03/01/2005 | CA2288334C Method of manufacturing sertindole |
| 03/01/2005 | CA2255691C Cosmetic or pharmaceutical preparations with a reduced feeling of stickiness |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 02/24/2005 | WO2005017526A1 Reconstitution medium for protein and peptide formulations |
| 02/24/2005 | WO2005017079A1 Process for the purification of non-ionic solvants for stabilized injectable pharmaceutical formulaitons |
| 02/24/2005 | WO2005016974A1 Sialic acid derivatives for protein derivatisation and conjugation |
| 02/24/2005 | WO2005016973A1 Polysialic acid derivatives |
| 02/24/2005 | WO2005016949A2 Sialic acid derivatives |
| 02/24/2005 | WO2005016414A2 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 02/24/2005 | WO2005016386A1 Improved therapeutic protocols |
| 02/24/2005 | WO2005016385A1 Insecticidal and acaricidal compositions with uv blockers and pheromones |
| 02/24/2005 | WO2005016365A2 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 02/24/2005 | WO2005016360A1 Topical compositions of ammonium lactate |
| 02/24/2005 | WO2005016355A1 Intravascular delivery of non-viral nucleic acid |
| 02/24/2005 | WO2005016345A1 Multivitamin syrup for children or young adults |
| 02/24/2005 | WO2005016341A1 Extended release analgesic for pain control |
| 02/24/2005 | WO2005016329A1 Topical compositions of urea and ammonium lactate |
| 02/24/2005 | WO2005016328A1 Topical compositions of urea |
| 02/24/2005 | WO2005016322A2 Pharmaceutical compositions of lavendustin |
| 02/24/2005 | WO2005016320A1 Dermal or transdermal therapeutic system comprising an ormocer with barrier effect on a cover foil |
| 02/24/2005 | WO2005016312A1 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 02/24/2005 | WO2005016308A1 Macrolides containing oil-in-water emulsions |
| 02/24/2005 | WO2005016307A1 Steroidal compositions containing hydroxycarboxylic acids and methods of using the same |
| 02/24/2005 | WO2005016296A1 Emulsive composition containing dapsone |
| 02/24/2005 | WO2005016290A1 Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
| 02/24/2005 | WO2005016262A2 Methods for administering aripiprazole |
| 02/24/2005 | WO2005016260A2 Prodrugs for the oral and parenteral delivery of amine-containing drugs, amino acids, and peptides |
| 02/24/2005 | WO2005016257A2 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/24/2005 | WO2005016256A2 Hemostatic compositions containing sterile thrombin |
| 02/24/2005 | WO2005016246A2 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 02/24/2005 | WO2005016225A2 Stable pharmaceutical composition of rabeprazole |
| 02/24/2005 | WO2005016115A2 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 02/24/2005 | WO2005016031A1 Methods for reducing astringency |
| 02/24/2005 | WO2005015993A1 Insect control using attractants and insecticides stabilised in castor oil |
| 02/24/2005 | WO2004112630A3 A formulation and a process for reducing the deterioration of blood with particular reference to decrease in the level of 2,3 diphosphoglycerate during storage |
| 02/24/2005 | WO2004105800A3 Complexing of medicinal substances with high-molecular strength |
| 02/24/2005 | WO2004100926A3 Delivery of agents using hydrolyzable leaving groups |
| 02/24/2005 | WO2004098535A9 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/24/2005 | WO2004093799A3 Thyroid receptor ligands |
| 02/24/2005 | WO2004091529A3 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |